Charytan, David M
- NYU Grossman School of Medicine · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #9,454
- Rising Star
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2010 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$1.1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#9,454
By linked amount among FY2023 PIs
Earliest Year Loaded
2010
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Charytan, David M as a PI. Multi-PI records show the full award amount for context.
- 5R01HL157220-02R01Contact PIIntradialytic Myocardial Stunning in Hemodialysis Patients - a Novel Cardiovascular Risk FactorNYU Grossman School of Medicine · Internal Medicine (NIH department code)$692.7Kaward amount
- 1R01DK133871-01A1R01Contact PISafety and Efficacy of Empagliflozin Main intenance HD (SEED)NYU Grossman School of Medicine · Internal Medicine (NIH department code)$364.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Charytan, David M as a PI.
FY2023 award administered by NYU Grossman School of Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2010First NIH AwardNYU Grossman School of Medicine
- 2013$500K Cumulative Funding
- 2014$1M Cumulative Funding
- 2014$2M Cumulative Funding
- 2014Entered Top 50% NationallyRanked #5574
- 2014R01 Grant Holder
- 2019$5M Cumulative Funding
- 2019Entered Top 25% NationallyRanked #1364
- 2019Entered Top 10% NationallyRanked #1364